SORAFENIB
Generic: SORAFENIB
Yabao Pharmaceutical Co.Manufacturer
ORALRoute
SORAFENIBActive Substance
2022-11-09Original Approval
SORAFENIB is FDA application ANDA209050, sponsored by YABAO PHARM. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
DIARRHOEA
457 reports
2
OFF LABEL USE
454 reports
3
FATIGUE
304 reports
4
ANAEMIA
278 reports
5
THROMBOCYTOPENIA
265 reports
6
NAUSEA
260 reports
7
PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME
258 reports
8
DEATH
248 reports
9
DISEASE PROGRESSION
243 reports
10
MALIGNANT NEOPLASM PROGRESSION
238 reports